CARIBOU in Chile
The CARIBOU Pathway is expanding internationally!
The CARIBOU-2 Pathway is a multi-component treatment pathway for young people with depression, originally developed in English in Canada by the Centre for Addiction and Mental Health (CAMH). The pathway has since been adapted into Spanish and piloted for efficacy and acceptability in Chile. The Spanish-language version of the pathway was piloted in a randomized controlled clinical trial in Chile, led by Dr. Jorge Gaete, a psychiatrist and researcher at the Universidad de los Andes in Santiago. The study was conducted in school settings and recruited youth with moderate to high levels of depression. Results demonstrated a significant reduction in depressive symptoms, and the pathway was rated as highly acceptable by participating youth.
What’s next?
The CARIBOU Pathway is expanding internationally!
The CARIBOU-2 Pathway is a multi-component treatment pathway for young people with depression, originally developed in English in Canada by the Centre for Addiction and Mental Health (CAMH). The pathway has since been adapted into Spanish and piloted for efficacy and acceptability in Chile. The Spanish-language version of the pathway was piloted in a randomized controlled clinical trial in Chile, led by Dr. Jorge Gaete, a psychiatrist and researcher at the Universidad de los Andes in Santiago. The study was conducted in school settings and recruited youth with moderate to high levels of depression. Results demonstrated a significant reduction in depressive symptoms, and the pathway was rated as highly acceptable by participating youth.
What’s next?
- A peer-reviewed article reporting the pilot findings will be available soon.
- In 2026, Dr. Jorge Gaete will lead a second cohort of the CARIBOU-2 Pathway in Chilean school settings, as well as a new study evaluating the implementation of the pathway in clinical settings in Chile.
- The Spanish version of CARIBOU is now available on CAMH’s website.